News

25.11.2022

Participation in the XI Congress of the National Association of Phthisiologists

The company GenTerra, represented by the head of the laboratory of RNA Biotechnology, Ph.D. Sergeeva O.V., took part in the XI Congress of the National Association of Phthisiologists and presented a report on "The use of synthetic oligonucleotides for the diagnosis and complex therapy of tuberculosis."

The theme of the Congress: "Modern trends in the development of phthisiology: scientific developments, interdisciplinary integration, results and prospects"
The main directions of the congress:
• epidemiology, prevention, early detection, differential diagnosis and effective treatment of tuberculosis;
• COVID-19 pandemic and tuberculosis;
• features of diagnosis and treatment of tuberculosis in people with HIV infection;
• fundamentals of tuberculosis pathogenesis and biological characteristics of its pathogens;
• interdisciplinary interactions of phthisiology with other specialties;
• changes in the principles of MDR/XDR tuberculosis treatment;
• infection control in antitubercular institutions: modern norms and reality;
• breakthroughs and proven methods in the diagnosis and treatment of chronic infectious lesions, including tuberculosis of extrapulmonary localization.

Detailed information about the event is available on the website of the National Association of Phthisiologists: http://nasph.ru/